<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>المجلد الاول العدد 1 2022</title>
<link>http://dspace-su.server.ly:8080/xmlui/handle/123456789/2687</link>
<description/>
<pubDate>Sun, 10 May 2026 12:43:10 GMT</pubDate>
<dc:date>2026-05-10T12:43:10Z</dc:date>
<image>
<title>المجلد الاول العدد 1 2022</title>
<url>http://dspace.lslab.ly:8080/xmlui/bitstream/id/01ea9d84-8dbb-4317-bb94-3e0d26a30c19/</url>
<link>http://dspace-su.server.ly:8080/xmlui/handle/123456789/2687</link>
</image>
<item>
<title>Serologic survey of leishmaniasis in Ibn Sina patients, Sirte, Libya.</title>
<link>http://dspace-su.server.ly:8080/xmlui/handle/123456789/2696</link>
<description>Serologic survey of leishmaniasis in Ibn Sina patients, Sirte, Libya.
Bagar, Shaban R. A.; Daw, Mohammed A.; Elkasah, Fathi.s.; etbiga, Abdalla Mahdi
The clinical and parasitological features of leishmaniasis were investigated, retrospectively, in 162 patients who attended the out-patient clinic of Ibn Sina hospital during January 2017 and June 2018. The aim was to evaluate the epidemiological characteristics of leishmaniasis. Sera from all the suspected patients were examined for slit and smear examination.&#13;
&#13;
 Seventy one represent (43.82%) of 162 were positive. Of them, 52 (73%) were males and 19 (26.76%) females. The most affected age group was found to be between 21 and 30; the least affected was age group below 10 years.
</description>
<pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://dspace-su.server.ly:8080/xmlui/handle/123456789/2696</guid>
<dc:date>2022-06-01T00:00:00Z</dc:date>
</item>
<item>
<title>Perception Towards Cigarette Smoking And Awareness Of Risk Of Cigarette Smoking Among Sibu Population In Sibu District From April To July 2020.</title>
<link>http://dspace-su.server.ly:8080/xmlui/handle/123456789/2695</link>
<description>Perception Towards Cigarette Smoking And Awareness Of Risk Of Cigarette Smoking Among Sibu Population In Sibu District From April To July 2020.
Etbiga, Abdalla; Sharada, Muftah Ben; Alhussin Ali, Abdalmawla; BalaSubramonie, Praghazshini a/p
Background: Cigarette smoking is a crucial public health problem with 1.3 billion smokers around the world, causing 5 million death annually. In Malaysia, the prevalence of cigarette smoking among both male and female Malaysian adults aged 15 years and above is 23.1%, and is highest in those aged 21-30 years old. Although majority of people in Malaysia have knowledge on harmfulness of smoking and second-hand smoke, their perception towards smoking is not clearly determined. Thus, we conducted a study to determine the perception and awareness of risk of cigarette smoking in Sibu community.
</description>
<pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://dspace-su.server.ly:8080/xmlui/handle/123456789/2695</guid>
<dc:date>2022-06-01T00:00:00Z</dc:date>
</item>
<item>
<title>Intranasal Drops Of Ketamine versus Midazolam for Preoperative Pediatric Sedation In General Surgical Procedures</title>
<link>http://dspace-su.server.ly:8080/xmlui/handle/123456789/2694</link>
<description>Intranasal Drops Of Ketamine versus Midazolam for Preoperative Pediatric Sedation In General Surgical Procedures
B.Ali, Mohammed; Almabsoot, Abdalmanam; M. Amaigil, Hussain
Premedication in the pediatric age group presents a challenging situation. The young children are not fully able to understand the necessity for their surgery. Fear of operating theater, injections and separation from parents prior to anesthesia produce traumatic experiences in tend mind of young children. In the past, psychological preparation was only used before surgery. Later on, many drugs like morphine, paraldehyde, meperedine, diazepam and barbiturates have been used.&#13;
&#13;
The aim of this study is to compare the effects and the side effects of intranasal ketamine versus midazolam administrated for pediatric premedication.&#13;
&#13;
In this study we evaluate and compare intranasal ketamine versus midazolam as premedication in pediatric anesthesia according to  the onset of sedation, degree of sedation , easy cannulation, acceptance of mask before intubation, hemodynamic changes regarding heart rate, mean blood pressure, respiratory rate and intraoperative oral secretion grading.&#13;
&#13;
This study was a double blinded randomized controlled study which was carried out at ibn sina Hospitals from February 2018 to January 2020. This study included 54 Child aged from 5 to 8 years admitted to the ibn sina Hospitals for general surgical procedures e.g herniotomy, tonsillectomy and hypospadias etc. All the patients completed the study.&#13;
&#13;
 Regarding the onset of sedation: the result of this study found that onset of sedation was earlier in the intranasal midazolam as The  onset of sedation for ketamine group and midazolam group was respectively 14.96 ± 3.1 and 8.16 ±2.1. Most patients became sedated 6-10 minutes when compared to intranasal ketamine as most patients sedated after 16-20 minutes.&#13;
&#13;
 We recommend the use of intranasal ketamine and midazolam as preoperative pediatric sedatives to decrease anxiety of children before start of general anesthesia to overcome drawbacks of pediatric anxiety and fear postoperatively and Intranasal midazolam was better than ketamine according to onset of sedation which started earlier and intraoperative secretions were scanty with midazolam in comparison with ketamine.
</description>
<pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://dspace-su.server.ly:8080/xmlui/handle/123456789/2694</guid>
<dc:date>2022-06-01T00:00:00Z</dc:date>
</item>
<item>
<title>Emerging of leishmaniasis in Zamzum, Libya</title>
<link>http://dspace-su.server.ly:8080/xmlui/handle/123456789/2693</link>
<description>Emerging of leishmaniasis in Zamzum, Libya
Elkasah, Fathi S.; Dow, Mohammed A.; Lahwal, *, Abdulla M.
A pilot study on leishmaniasis was carried in the outpatient clinic, Zamzam, Libya, from 4 October 2018 to 31 May 2019. A total of 84 patients with cutaneous leishmaniasis (CL) were studied. The duration of the lesions varied from a few days to 3 months. Multiple lesions ranging from one to 21 were present in 78% of cases. Ulcerative lesions were found in 37%, nodulo-ulcerative in 22%, nodular in 30% and others, including infiltrated, fungating and warty lesions, in 3% of patients. The lower limbs were involved in 66%, upper limbs in 36% (Figure. 1), face in 89%, back in 6%, chest in 1%, and abdomen in 2%. Lesions were also found on the ear, scalp, genitalia and mucocutaneous junctions. Lymphatic involvement was present in 9% of the patients, secondary infection in 10%, fever in 12%, and pain in 40% and itching in 72%. Features of diffuse cutaneous leishmaniasis were noted in 3 patients. Slit skin smear was positive for parasites in 67 cases (highly positive in 34 cases). Various therapeutic regimens are discussed. Only patients with severe lesions (approximately 21%) were given 3 to 4 weeks' treatment with intravenous Pentostam, to which all except 4 responded satisfactorily with minimal side effects
</description>
<pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://dspace-su.server.ly:8080/xmlui/handle/123456789/2693</guid>
<dc:date>2022-06-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
